1. Home
  2. KALA vs DUOT Comparison

KALA vs DUOT Comparison

Compare KALA & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • DUOT
  • Stock Information
  • Founded
  • KALA 2009
  • DUOT 1990
  • Country
  • KALA United States
  • DUOT United States
  • Employees
  • KALA N/A
  • DUOT N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • KALA Health Care
  • DUOT Technology
  • Exchange
  • KALA Nasdaq
  • DUOT Nasdaq
  • Market Cap
  • KALA 28.2M
  • DUOT 17.9M
  • IPO Year
  • KALA 2017
  • DUOT N/A
  • Fundamental
  • Price
  • KALA $6.00
  • DUOT $2.35
  • Analyst Decision
  • KALA Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • KALA 2
  • DUOT 1
  • Target Price
  • KALA $16.50
  • DUOT $5.75
  • AVG Volume (30 Days)
  • KALA 8.4K
  • DUOT 24.8K
  • Earning Date
  • KALA 08-06-2024
  • DUOT 08-13-2024
  • Dividend Yield
  • KALA N/A
  • DUOT N/A
  • EPS Growth
  • KALA N/A
  • DUOT N/A
  • EPS
  • KALA N/A
  • DUOT N/A
  • Revenue
  • KALA N/A
  • DUOT $5,638,027.00
  • Revenue This Year
  • KALA N/A
  • DUOT $82.13
  • Revenue Next Year
  • KALA N/A
  • DUOT $67.91
  • P/E Ratio
  • KALA N/A
  • DUOT N/A
  • Revenue Growth
  • KALA N/A
  • DUOT N/A
  • 52 Week Low
  • KALA $4.21
  • DUOT $1.94
  • 52 Week High
  • KALA $11.81
  • DUOT $5.74
  • Technical
  • Relative Strength Index (RSI)
  • KALA 46.60
  • DUOT 42.59
  • Support Level
  • KALA $5.84
  • DUOT $2.22
  • Resistance Level
  • KALA $6.14
  • DUOT $2.40
  • Average True Range (ATR)
  • KALA 0.24
  • DUOT 0.19
  • MACD
  • KALA 0.02
  • DUOT -0.00
  • Stochastic Oscillator
  • KALA 36.23
  • DUOT 24.07

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: